Streetbeat News

Stock Prices

CLLS

Cellectis has presented pre-clinical evidence showing that their TALEN-edited MUC1 CAR T-cells can effectively reduce triple-negative breast cancer while maintaining safety. This development is significant for the company's research and potential future treatments.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 8:31 pm

ATHA

Athira Pharma shares have resumed trading after a temporary halt. This development is significant for investors as it may impact the stock's short-term price movement.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 8:31 pm

NEE

NextEra Energy (NYSE:NEE) has seen a surge in options activity, with a significant bearish sentiment among big-money traders. The options trades include 7 puts and 12 calls, with a total trade value of over $1.7 million. Analysts have mixed ratings on NEE, with price targets ranging from $76 to $102.

Portfolio Pulse from Benzinga Insights

September 03, 2024 | 8:30 pm

HPE

Hewlett Packard Enterprise Co (NYSE:HPE) is set to report its Q3 earnings with expectations of 47 cents EPS and $7.66 billion in revenue. The stock has shown a mixed technical outlook, with bullish short-term signals but bearish medium-term trends. Analysts have a neutral rating with a 24% upside potential.

Portfolio Pulse from Surbhi Jain

September 03, 2024 | 8:30 pm

ACB

CARA

CRBP

CRON

EAST

OGI

XXII

On September 3, 2024, several marijuana stocks experienced significant price movements. Notable gainers included AusCann Group Holdings, Global Hemp Group, and Cronos Group, while Kaya Holdings and Leafbuyer Techs were among the biggest losers.

Portfolio Pulse from Benzinga Insights

September 03, 2024 | 8:30 pm

ATRA

Atara Biotherapeutics shares rose following the announcement of a $36 million registered direct offering of 758,900 shares at $8.25 each.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 8:27 pm

PD

PagerDuty shares declined following the release of disappointing Q2 sales results.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 8:27 pm

PD

PagerDuty reported Q2 2025 earnings per share of $0.21, surpassing the expected $0.17, but its sales of $115.9 million slightly missed the $116.477 million estimate. Sales increased by 7.7% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 8:26 pm

SHPH

Shuttle Pharmaceuticals shares rose following the grant of patent #12077515 for their selective histone deacetylase inhibitors.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 8:25 pm

ATHA

The trading halt status was updated at 4:25 PM ET, indicating a resumption of quotations. This update may involve the company Athira Pharma, Inc. (ATHA).

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 8:25 pm